JP2009523711A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009523711A5 JP2009523711A5 JP2008546192A JP2008546192A JP2009523711A5 JP 2009523711 A5 JP2009523711 A5 JP 2009523711A5 JP 2008546192 A JP2008546192 A JP 2008546192A JP 2008546192 A JP2008546192 A JP 2008546192A JP 2009523711 A5 JP2009523711 A5 JP 2009523711A5
- Authority
- JP
- Japan
- Prior art keywords
- formula
- alkyl
- group
- alkylamino
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229910052739 hydrogen Inorganic materials 0.000 claims description 31
- 239000001257 hydrogen Substances 0.000 claims description 31
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 23
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims description 21
- 229910052731 fluorine Inorganic materials 0.000 claims description 21
- 239000011737 fluorine Substances 0.000 claims description 21
- 125000003282 alkyl amino group Chemical group 0.000 claims description 20
- 150000001875 compounds Chemical class 0.000 claims description 20
- 239000012453 solvate Substances 0.000 claims description 18
- 125000000392 cycloalkenyl group Chemical group 0.000 claims description 17
- 150000003839 salts Chemical class 0.000 claims description 17
- -1 trifluoromethoxy, amino Chemical group 0.000 claims description 17
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims description 16
- 229910052760 oxygen Inorganic materials 0.000 claims description 16
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 16
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 claims description 15
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 15
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 15
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 15
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 14
- 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 claims description 12
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 12
- 229910052801 chlorine Inorganic materials 0.000 claims description 12
- 239000000460 chlorine Substances 0.000 claims description 12
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 9
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 claims description 8
- 125000001424 substituent group Chemical group 0.000 claims description 8
- 125000002252 acyl group Chemical group 0.000 claims description 7
- 125000004442 acylamino group Chemical group 0.000 claims description 7
- 125000004432 carbon atom Chemical group C* 0.000 claims description 7
- 125000001153 fluoro group Chemical group F* 0.000 claims description 7
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 claims description 7
- 125000004414 alkyl thio group Chemical group 0.000 claims description 5
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 5
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims description 5
- 229910052736 halogen Inorganic materials 0.000 claims description 5
- 150000002367 halogens Chemical class 0.000 claims description 5
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 claims description 5
- 125000006700 (C1-C6) alkylthio group Chemical group 0.000 claims description 4
- 125000006650 (C2-C4) alkynyl group Chemical group 0.000 claims description 4
- 125000003341 7 membered heterocyclic group Chemical group 0.000 claims description 4
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims description 4
- 241000238366 Cephalopoda Species 0.000 claims description 4
- 150000001335 aliphatic alkanes Chemical class 0.000 claims description 4
- 125000001072 heteroaryl group Chemical group 0.000 claims description 4
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 4
- 229910052717 sulfur Inorganic materials 0.000 claims description 4
- 238000006243 chemical reaction Methods 0.000 claims description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 7
- 239000012442 inert solvent Substances 0.000 claims 7
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 7
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 claims 6
- 150000002431 hydrogen Chemical class 0.000 claims 6
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 5
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims 4
- 125000000217 alkyl group Chemical group 0.000 claims 4
- 239000003814 drug Substances 0.000 claims 4
- 125000006729 (C2-C5) alkenyl group Chemical group 0.000 claims 3
- 208000024172 Cardiovascular disease Diseases 0.000 claims 3
- 125000001664 diethylamino group Chemical group [H]C([H])([H])C([H])([H])N(*)C([H])([H])C([H])([H])[H] 0.000 claims 3
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 2
- 239000003054 catalyst Substances 0.000 claims 2
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims 2
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims 2
- 125000002433 cyclopentenyl group Chemical group C1(=CCCC1)* 0.000 claims 2
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims 2
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 claims 2
- 125000000623 heterocyclic group Chemical group 0.000 claims 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 229910052763 palladium Inorganic materials 0.000 claims 2
- 125000003386 piperidinyl group Chemical group 0.000 claims 2
- 230000002265 prevention Effects 0.000 claims 2
- 125000000719 pyrrolidinyl group Chemical group 0.000 claims 2
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims 2
- 229920002554 vinyl polymer Chemical group 0.000 claims 2
- 125000006570 (C5-C6) heteroaryl group Chemical group 0.000 claims 1
- 101100132433 Arabidopsis thaliana VIII-1 gene Proteins 0.000 claims 1
- 101100459319 Arabidopsis thaliana VIII-2 gene Proteins 0.000 claims 1
- 241001465754 Metazoa Species 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 239000013543 active substance Substances 0.000 claims 1
- 230000006806 disease prevention Effects 0.000 claims 1
- 150000002148 esters Chemical class 0.000 claims 1
- 125000000031 ethylamino group Chemical group [H]C([H])([H])C([H])([H])N([H])[*] 0.000 claims 1
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 125000002757 morpholinyl group Chemical group 0.000 claims 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 1
- 231100000252 nontoxic Toxicity 0.000 claims 1
- 230000003000 nontoxic effect Effects 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- 229940127557 pharmaceutical product Drugs 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- 125000000547 substituted alkyl group Chemical group 0.000 claims 1
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 claims 1
- 125000001412 tetrahydropyranyl group Chemical group 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102005061171A DE102005061171A1 (de) | 2005-12-21 | 2005-12-21 | Neue, cyclisch substituierte Furopyrimidin-Derivate und ihre Verwendung |
| PCT/EP2006/011825 WO2007079861A1 (de) | 2005-12-21 | 2006-12-08 | Neue, zyklisch substituierte furopyrimidin-derivate und ihre verwendung zur behandlung von kardiovaskulären erkrankungen |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009523711A JP2009523711A (ja) | 2009-06-25 |
| JP2009523711A5 true JP2009523711A5 (OSRAM) | 2010-01-28 |
Family
ID=37758644
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008546192A Pending JP2009523711A (ja) | 2005-12-21 | 2006-12-08 | 新規環状置換フロピリミジン誘導体および心臓血管疾患を処置するためのその使用 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US8324222B2 (OSRAM) |
| EP (1) | EP1966218B1 (OSRAM) |
| JP (1) | JP2009523711A (OSRAM) |
| KR (1) | KR20080081325A (OSRAM) |
| CN (1) | CN101384602A (OSRAM) |
| AT (1) | ATE473982T1 (OSRAM) |
| AU (1) | AU2006334855A1 (OSRAM) |
| BR (1) | BRPI0620647A2 (OSRAM) |
| CA (1) | CA2633698A1 (OSRAM) |
| DE (2) | DE102005061171A1 (OSRAM) |
| ES (1) | ES2347593T3 (OSRAM) |
| IL (1) | IL192081A0 (OSRAM) |
| RU (1) | RU2008129364A (OSRAM) |
| WO (1) | WO2007079861A1 (OSRAM) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102007019690A1 (de) * | 2007-04-26 | 2008-10-30 | Bayer Healthcare Ag | Verwendung von cyclisch substituierten Furopyrimidin-Derivaten zur Behandlung der pulmonalen arteriellen Hypertonie |
| DE102007027800A1 (de) * | 2007-06-16 | 2008-12-18 | Bayer Healthcare Ag | Substituierte bicyclische Heteroaryl-Verbindungen und ihre Verwendung |
| DE102007051762A1 (de) | 2007-10-30 | 2009-05-07 | Bayer Healthcare Ag | Substituierte Pyrrolotriazine und ihre Verwendung |
| DE102007054786A1 (de) | 2007-11-16 | 2009-05-20 | Bayer Healthcare Ag | Trisubstituierte Furopyrimidine und ihre Verwendung |
| KR101314508B1 (ko) * | 2008-08-25 | 2013-10-07 | 듀퐁 일렉트로닉 폴리머스 엘피 | 신규한 프로파노에이트 및 그의 제조 방법 |
| US20240002395A1 (en) * | 2020-12-04 | 2024-01-04 | The Johns Hopkins University | Compounds and their use for treating neuropathic pain |
| CN115462369B (zh) * | 2022-09-29 | 2023-09-22 | 安徽省立医院(中国科学技术大学附属第一医院) | 一种玻璃化冷冻外泌体保存方法 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3577420A (en) | 1968-01-05 | 1971-05-04 | Pfizer | Certain 4-aminofuro(2,3-d)pyrimidines |
| ATE266662T1 (de) | 1998-07-22 | 2004-05-15 | Daiichi Suntory Pharma Co Ltd | Nf-kappa b inhibitoren, die indanderivate als aktiven bestandteil enthalten |
| HK1045306A1 (zh) | 1999-06-03 | 2002-11-22 | Abbott Laboratories | 抑制细胞黏附的抗炎化合物 |
| AU7315400A (en) | 1999-09-17 | 2001-04-24 | Daiichi Suntory Pharma Co., Ltd | Preventives or remedies for myocarditis, dilated cardiomyopathy and cardiac insufficiency containing NF-kappab inhibitors as the active ingredient |
| WO2002092603A1 (en) | 2001-05-14 | 2002-11-21 | Novartis Ag | Oxazolo-and furopyrimidines and their use in medicaments against tumors |
| DE10141212A1 (de) * | 2001-08-22 | 2003-03-06 | Bayer Ag | Neue 4-Aminofuropyrimidine und ihre Verwendung |
| WO2003022852A2 (en) | 2001-09-11 | 2003-03-20 | Smithkline Beecham Corporation | Furo-and thienopyrimidine derivatives as angiogenesis inhibitors |
| DE10148883A1 (de) * | 2001-10-04 | 2003-04-10 | Merck Patent Gmbh | Pyrimidinderivate |
| US20030225098A1 (en) * | 2002-03-21 | 2003-12-04 | Hirst Gavin C. | Kinase inhibitors |
| KR20050091462A (ko) | 2004-03-12 | 2005-09-15 | 한국과학기술연구원 | 푸로피리미딘 화합물 및 이를 포함하는 ｄｄｒ2 티로신키나아제 활성 저해제 |
| KR20070055486A (ko) | 2004-06-10 | 2007-05-30 | 젠션 디스커버리 리미티드 | 포타슘 채널 억제제로서 유효한 퓨라노피리미딘 화합물 |
| EP1768986A2 (en) * | 2004-06-29 | 2007-04-04 | Amgen Inc. | Furanopyrimidines |
-
2005
- 2005-12-21 DE DE102005061171A patent/DE102005061171A1/de not_active Withdrawn
-
2006
- 2006-12-08 ES ES06840964T patent/ES2347593T3/es active Active
- 2006-12-08 BR BRPI0620647-6A patent/BRPI0620647A2/pt not_active IP Right Cessation
- 2006-12-08 KR KR1020087017645A patent/KR20080081325A/ko not_active Withdrawn
- 2006-12-08 DE DE502006007450T patent/DE502006007450D1/de active Active
- 2006-12-08 AU AU2006334855A patent/AU2006334855A1/en not_active Abandoned
- 2006-12-08 RU RU2008129364/04A patent/RU2008129364A/ru not_active Application Discontinuation
- 2006-12-08 EP EP06840964A patent/EP1966218B1/de not_active Not-in-force
- 2006-12-08 WO PCT/EP2006/011825 patent/WO2007079861A1/de not_active Ceased
- 2006-12-08 US US12/086,784 patent/US8324222B2/en not_active Expired - Fee Related
- 2006-12-08 AT AT06840964T patent/ATE473982T1/de active
- 2006-12-08 CA CA002633698A patent/CA2633698A1/en not_active Abandoned
- 2006-12-08 CN CNA200680053205XA patent/CN101384602A/zh active Pending
- 2006-12-08 JP JP2008546192A patent/JP2009523711A/ja active Pending
-
2008
- 2008-06-12 IL IL192081A patent/IL192081A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2014219283C1 (en) | Benzothiophene derivatives and compositions thereof as selective estrogen receptor degraders | |
| AP1122A (en) | Therapeutically active compounds based on based on based on indazole bioisostere replacement of catechol in PDE4 inhibitors. | |
| JP7671245B2 (ja) | ピリダジノン化合物およびその使用 | |
| UA77532C2 (en) | Pyridazin-3(2h)-one derivatives as phosphodiesterase 4 inhibitors | |
| JP2008511601A5 (OSRAM) | ||
| NO20064151L (no) | Nye forbindelser | |
| MX2014007230A (es) | Derivados de tieno [3,2 - d]pirimidina que tienen actividad inhibidora de las cinasas de proteina. | |
| JP2009084270A5 (OSRAM) | ||
| EP3227270A2 (en) | Heterocyclic derivatives and use thereof | |
| JP2006502119A5 (OSRAM) | ||
| JP2021508318A (ja) | チューブリン阻害剤 | |
| TW200836739A (en) | Substituted 2, 5-dihydro-3H-pyrazolo[4, 3-c] pyridazin-3-one derivatives, preparation thereof and therapeutic use thereof | |
| AU2016324495A1 (en) | Carborane compounds and methods of use thereof | |
| JP5833143B2 (ja) | フェニル−イソオキサゾール誘導体およびその製造方法 | |
| JP2015502371A5 (OSRAM) | ||
| JP2007538031A5 (OSRAM) | ||
| JP2009523711A5 (OSRAM) | ||
| CN110612286A (zh) | 氰基取代的稠合双环衍生物及其制备方法和用途 | |
| JP2005508954A5 (OSRAM) | ||
| AU2019227250A1 (en) | 10-(di(phenyl)methyl)-4-hydroxy-8,9,9a,10-tetrahydro-7H-pyrrolo[1 ',2':4,5]pyrazino[1,2-b]pyridazine-3,5-dione derivatives and related compounds as inhibitors of the orthomyxovirus replication for treating influenza | |
| JP2007507473A5 (OSRAM) | ||
| KR20100096512A (ko) | 4,5-디아릴-3(2ｈ)-퓨라논 유도체 또는 그의 약학적으로 허용가능한 염을 포함하는 인지능력 개선용 약학 조성물 | |
| RU2008129364A (ru) | Новые циклически замещенные производные фуропиримидина и их применение для лечения сердечно-сосудистых заболеваний | |
| JP2008520611A5 (OSRAM) | ||
| JP2017514867A5 (OSRAM) |